seen as an anticipated newsflow/milestone dated for Q2 2021, I would like to see an ann that this toxicology study has indeed been initiated. n They tend to bring out an ann after the fact and luckily thus far all positive.
Hope we do not have to wait much longer for some information around this
Would commencement of these tox studies require PET to ann this as part of regulatory continuous disclosure????
Ann: Full size deoxymab PAT-DX3 crosses the blood brain barrier, page-81
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
